Announcement on Voluntary Disclosure on the Acceptance of Clinical Trial Registration Application for GB10 Injection

About this update from Kexing Biopharm Co., Ltd. Class A

Announcement on Voluntary Disclosure on the Acceptance of Clinical Trial Registration Application for GB10 InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Kexing Biopharm Co., Ltd. Class A